𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system

✍ Scribed by Hiroko Ohgaki; Robert H. Eibl; Martin B. Reichel; Luigi Mariani; Iver Petersen; Thomas Höll; Otmar D. Wiestler; Paul Kleihues; Manfred Schwab; Manuela Gehring

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
650 KB
Volume
8
Category
Article
ISSN
0899-1987

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A variety of neoplasms of the human nervous system were analyzed for the presence of mutations in the p53 tumor suppressor gene. DNA was extracted from frozen or formalin‐fixed, paraffin‐embedded material. Single‐strand conformation polymorphism (SSCP) analysis for exons 5–8 was followed by direct DNA sequencing. Mutations leading to an amino acid change were found in three of 11 (27%) low‐grade (World Health Organization (WHO) Grade II) astrocytomas. They were located in codon 183 (TCA → TGA) of exon 5, codon 237 (ATG → ATA) of exon 7, and codon 273 (CGT → CAT) of exon 8. In one of these cases, the sequence indicated loss of the wild‐type allele. Of 12 juvenile pilocytic astrocytomas (WHO Grade I), none contained a p53 mutation, suggesting a different molecular basis for this childhood neoplasm. Except for a mutation in one of seven (14%) meningeal hemangiopericytomas (codon 238; TGT → TTT, Cys → Phe), no mutations were observed in exons 5–8 of the p53 gene in any of the following tumors of the nervous system and its coverings: 13 schwannomas, 12 central neurocytomas, 22 meningiomas, 10 choroid plexus papillomas and carcinomas, and 30 neuroblastomas of the sympathetic nervous system. These and published data support the view that p53 mutations are frequently involved both in low‐grade and progressive (anaplastic) astrocytomas, including glioblastomas multiforme. Oligodendrogliomas, medulloblastomas, meningiomas, and hemangiopericytomas rarely (<15%) show p53 mutations in exons 5–8, whereas none of the remaining nervous system neoplasms revealed evidence of an involvement of the p53 gene in their development.

📜 SIMILAR VOLUMES

Mutations of p53 tumor-suppressor gene i
Mutations of p53 tumor-suppressor gene in angiosarcoma
✍ Norifumi Naka; Yasuhiko Tomita; Hirofumi Nakanishi; Nobuhito Araki; Tadashi Hong 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 50 KB 👁 3 views

Transgenic mice deficient for the p53 gene were reported to frequently develop angiosarcoma (AS), suggesting that alterations in the gene are associated with tumorigenesis of AS. However, little is known about genetic changes, including p53 gene alterations, in human AS because of its rarity. We ana

Mutations in the p53 tumor suppressor ge
Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas
✍ William E. Pierceall; Tapas Mukhopadhyay; Leonard H. Goldberg; Honnavara N. Anan 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 528 KB

In this study, we analyzed 10 human squamous cell carcinomas (SCCs) for alterations in the p53 tumor suppressor gene in exons 4 through 9 by single-strand conformation polymorphism (SSCP) analysis. We found that 2 of 10 SCCs displayed unusual SSCP alleles at exon 7 of the p53 gene. Subsequent clonin

Mutations of the p53 tumor suppressor ge
Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand
✍ Takayoshi Kiba; Hitoshi Tsuda; Setsuo Hirohashi; Shuji Inoue; Takashi Sugimura; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 618 KB

## Abstract The incidence and pattern of mutations of the __ras__ oncogenes and the __p53__ tumor suppressor gene have been shown to differ among different cancer types and even among the same cancer types with different etiological backgrounds. For example, in a previous study we showed that not o